Artking Global Limited - Net Worth and Insider Trading
Artking Global Limited Net Worth
The estimated net worth of Artking Global Limited is at least $10.1 Billion dollars as of 2024-05-25. Artking Global Limited is the 2501 Other of Simcere Pharmaceutical Group Ltd and owns about 1,802,267,668 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) stock worth over $10.1 Billion. Details can be seen in Artking Global Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Artking Global Limited has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).
Transaction Summary of Artking Global Limited
Artking Global Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Artking Global Limited owns 1 companies in total, including Simcere Pharmaceutical Group Ltd (HKSE:02096) .
Click here to see the complete history of Artking Global Limited’s form 4 insider trades.
Insider Ownership Summary of Artking Global Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02096 | Simcere Pharmaceutical Group Ltd | 2024-02-05 | 2501 Other |
Artking Global Limited Latest Holdings Summary
Artking Global Limited currently owns a total of 1 stock. Artking Global Limited owns 1,802,267,668 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) as of February 5, 2024, with a value of $10.1 Billion.
Latest Holdings of Artking Global Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02096 | Simcere Pharmaceutical Group Ltd | 2024-02-05 | 1,802,267,668 | 5.62 | 10,128,744,294 |
Holding Weightings of Artking Global Limited
Artking Global Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Artking Global Limited has made a total of 38 transactions in Simcere Pharmaceutical Group Ltd (HKSE:02096) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Simcere Pharmaceutical Group Ltd is the sale of 0 shares on February 5, 2024, which brought Artking Global Limited around $0.
Insider Trading History of Artking Global Limited
- 1
Artking Global Limited Trading Performance
Artking Global Limited Ownership Network
Artking Global Limited Owned Company Details
What does Simcere Pharmaceutical Group Ltd do?
Who are the key executives at Simcere Pharmaceutical Group Ltd?
Artking Global Limited is the 2501 Other of Simcere Pharmaceutical Group Ltd. Other key executives at Simcere Pharmaceutical Group Ltd include 2305 Beneficiary of a trust WANG XI , 2202 Interest of your spouse Ren Jinsheng , and 2501 Other Right Wealth Holdings Limited .
Simcere Pharmaceutical Group Ltd (HKSE:02096) Insider Trades Summary
Over the past 18 months, Artking Global Limited made no insider transaction in Simcere Pharmaceutical Group Ltd (HKSE:02096). Other recent insider transactions involving Simcere Pharmaceutical Group Ltd (HKSE:02096) include a net sale of 0 shares made by Ren Jinsheng , a net purchase of 6,216,000 shares made by Peng Suqin , and a net purchase of 732,000 shares made by Simcere Investments Group Limited .
In summary, during the past 3 months, insiders sold 0 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,301,000 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) were sold and 8,249,000 shares were bought by its insiders, resulting in a net purchase of 6,948,000 shares.
Simcere Pharmaceutical Group Ltd (HKSE:02096)'s detailed insider trading history can be found in Insider Trading Tracker table.
Simcere Pharmaceutical Group Ltd Insider Transactions
Artking Global Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Artking Global Limited. Currently GuruFocus does not have mailing address information for Artking Global Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
